Indian drug makers wary as US FDA sharpens focus on quality controlPost published:May 16, 2017Post category:Industry NewsThe US FDA has increased the frequency of its inspections but also intensified scrutiny on drug manufacturing facilities in India Source: Livemint.com (http://www.livemint.com/rss/industry)Read more articles Previous PostFacebook’s Sheryl Sandberg urges family-friendly policies on Mother’s Day Next PostLithium supply may be key to government’s electric vehicles push You Might Also Like EXAIR releases 3/8″ Standard Air Wipe August 7, 2019 Sensitivity Coefficients in Uncertainty Budgets March 1, 2018 VDA-5: Combining Uncertainty Evaluation with Gage Studies October 8, 2018